ASIA PACIFIC VASCULAR STENTS MARKET FORECAST 2018-2026
KEY FINDINGS Increase in the approval and availability of innovative products has significantly contributed to the growth of the market in Asia Pacific region. The development of the market is estimated at the fastest growing CAGR 8.15% over the forecast years. The market is evolving to $5791 million by 2026 from $2887 million in the year 2017. However, difficulties related to the use of the vascular stent is restraining the market growth in the region.
MARKET INSIGHTS The APAC region is classified into developing countries such as Japan, China, Australia, India, and rest of Asia Pacific. The APAC region is anticipated to be the rapidly evolving region for the vascular stent market over the forecast period. Product fiascos and recalls and the threat of substitutes for the vascular stent are few of the restricting factors that are affecting the growth of the market in the region. The market for vascular stent comprises of segments like end-user, materials, type, mode of delivery, and products.
COMPETITIVE INSIGHTS Some of the renowned players of the vascular stents market include Abbott Laboratories, Meril Life Sciences Private Limited, Vascular Concepts Limited (India), Medtronic Inc., Braun Melsungen Ag, Microport Scientific Corporation, Endologix Inc., Biotronik Se & Co. Kg, Translumina Gmbh, Terumo Corporation, W.L. Gore and Associates, Inc. (U.S.), Boston Scientific Corp., and Lombard Medical Technologies Inc.